par Francis, P;Crown, John;Di Leo, Angelo 
;Buyse, Marc;Balil, Ana M.;Andersson, Michael;Nordenskjöld, B;Lang, Istvan;Jakesz, Raimund;Vorobiof, Daniel;Gutierrez, J;van Hazel, Guy;Dolci, Stella;Jamin, Sophie;Bendahmane, Belguendouz;Gelber, R D;Goldhirsch, Aron;Castiglione-Gertsch, Monica;Piccart-Gebhart, Martine ;BIG 02-98 Collaborative Group,
Référence Journal of the National Cancer Institute, 100, 2, page (121-133)
Publication Publié, 2008-01
;Buyse, Marc;Balil, Ana M.;Andersson, Michael;Nordenskjöld, B;Lang, Istvan;Jakesz, Raimund;Vorobiof, Daniel;Gutierrez, J;van Hazel, Guy;Dolci, Stella;Jamin, Sophie;Bendahmane, Belguendouz;Gelber, R D;Goldhirsch, Aron;Castiglione-Gertsch, Monica;Piccart-Gebhart, Martine ;BIG 02-98 Collaborative Group, Référence Journal of the National Cancer Institute, 100, 2, page (121-133)
Publication Publié, 2008-01
Article révisé par les pairs
| Titre: |
|
| Auteur: | Francis, P; Crown, John; Di Leo, Angelo; Buyse, Marc; Balil, Ana M.; Andersson, Michael; Nordenskjöld, B; Lang, Istvan; Jakesz, Raimund; Vorobiof, Daniel; Gutierrez, J; van Hazel, Guy; Dolci, Stella; Jamin, Sophie; Bendahmane, Belguendouz; Gelber, R D; Goldhirsch, Aron; Castiglione-Gertsch, Monica; Piccart-Gebhart, Martine; BIG 02-98 Collaborative Group, |
| Informations sur la publication: | Journal of the National Cancer Institute, 100, 2, page (121-133) |
| Statut de publication: | Publié, 2008-01 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Adenocarcinoma -- chemistry |
| Adenocarcinoma -- drug therapy | |
| Adenocarcinoma -- pathology | |
| Adenocarcinoma -- surgery | |
| Adult | |
| Aged | |
| Antibiotics, Antineoplastic -- administration & dosage | |
| Antineoplastic Agents, Phytogenic -- administration & dosage | |
| Antineoplastic Combined Chemotherapy Protocols -- administration & dosage | |
| Antineoplastic Combined Chemotherapy Protocols -- adverse effects | |
| Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
| Breast Neoplasms -- chemistry | |
| Breast Neoplasms -- drug therapy | |
| Breast Neoplasms -- pathology | |
| Breast Neoplasms -- surgery | |
| Chemotherapy, Adjuvant | |
| Cyclophosphamide -- administration & dosage | |
| Disease-Free Survival | |
| Doxorubicin -- administration & dosage | |
| Drug Administration Schedule | |
| Estrogen Receptor Modulators -- administration & dosage | |
| Female | |
| Fluorouracil -- administration & dosage | |
| Follow-Up Studies | |
| Humans | |
| Immunohistochemistry | |
| Kaplan-Meiers Estimate | |
| Lymphatic Metastasis | |
| Mastectomy -- methods | |
| Methotrexate -- administration & dosage | |
| Middle Aged | |
| Odds Ratio | |
| Prospective Studies | |
| Receptors, Estrogen -- analysis | |
| Receptors, Progesterone -- analysis | |
| Tamoxifen -- administration & dosage | |
| Taxoids -- administration & dosage | |
| Treatment Outcome | |
| Note générale: | Clinical Trial, Phase III |
| Journal Article | |
| Multicenter Study | |
| Randomized Controlled Trial | |
| Research Support, N.I.H., Extramural | |
| Research Support, Non-U.S. Gov't | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0027-8874 |
| info:doi/10.1093/jnci/djm287 | |
| info:pii/djm287 | |
| info:scp/38449108413 | |
| info:pmid/18182617 |
